Your browser doesn't support javascript.
loading
Healthy lifestyle and the risk of pancreatic cancer in the EPIC study.
Naudin, Sabine; Viallon, Vivian; Hashim, Dana; Freisling, Heinz; Jenab, Mazda; Weiderpass, Elisabete; Perrier, Flavie; McKenzie, Fiona; Bueno-de-Mesquita, H Bas; Olsen, Anja; Tjønneland, Anne; Dahm, Christina C; Overvad, Kim; Mancini, Francesca R; Rebours, Vinciane; Boutron-Ruault, Marie-Christine; Katzke, Verena; Kaaks, Rudolf; Bergmann, Manuela; Boeing, Heiner; Peppa, Eleni; Karakatsani, Anna; Trichopoulou, Antonia; Pala, Valeria; Masala, Giovana; Panico, Salvatore; Tumino, Rosario; Sacerdote, Carlotta; May, Anne M; van Gils, Carla H; Rylander, Charlotta; Borch, Kristin Benjaminsen; Chirlaque López, María Dolores; Sánchez, Maria-Jose; Ardanaz, Eva; Quirós, José Ramón; Amiano Exezarreta, Pilar; Sund, Malin; Drake, Isabel; Regnér, Sara; Travis, Ruth C; Wareham, Nick; Aune, Dagfinn; Riboli, Elio; Gunter, Marc J; Duell, Eric J; Brennan, Paul; Ferrari, Pietro.
Afiliação
  • Naudin S; Nutritional Methodology and Biostatistics Group, International Agency for Research on Cancer, World Health Organization, 150, Cours Albert Thomas, 69372, Lyon Cedex 08, France.
  • Viallon V; Nutritional Methodology and Biostatistics Group, International Agency for Research on Cancer, World Health Organization, 150, Cours Albert Thomas, 69372, Lyon Cedex 08, France.
  • Hashim D; Department of Hematology and Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Freisling H; Nutritional Methodology and Biostatistics Group, International Agency for Research on Cancer, World Health Organization, 150, Cours Albert Thomas, 69372, Lyon Cedex 08, France.
  • Jenab M; Nutritional Epidemiology Group, International Agency for Research on Cancer, World Health Organization, Lyon, France.
  • Weiderpass E; Director Office, International Agency for Research on Cancer, World Health Organization, Lyon, France.
  • Perrier F; Nutritional Methodology and Biostatistics Group, International Agency for Research on Cancer, World Health Organization, 150, Cours Albert Thomas, 69372, Lyon Cedex 08, France.
  • McKenzie F; Environment and Radiation section, Agency for Research on Cancer, World Health Organization, Lyon, France.
  • Bueno-de-Mesquita HB; Departement for Determinants of Chronic Diseases (Former), National Institute of Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
  • Olsen A; Department of Gastroenterology and Hepathology, University Medical Center, Utrecht, The Netherlands.
  • Tjønneland A; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.
  • Dahm CC; Danish Cancer Society Research Center, Copenhagen, Denmark.
  • Overvad K; Danish Cancer Society Research Center, Copenhagen, Denmark.
  • Mancini FR; Department of Public Health, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Rebours V; Section for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark.
  • Boutron-Ruault MC; Section for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark.
  • Katzke V; Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark.
  • Kaaks R; CESP, Faculté de médecine (USVQ), Université Paris-Sud, INSERM, Université Paris-Saclay, Villejuif, France.
  • Bergmann M; Inserm UMR1018, Institut Gustave Roussy, Villejuif, France.
  • Boeing H; Pancreatology Department, Beaujon Hospital, AP-HP, Clichy, France.
  • Peppa E; Inserm UMR1149, DHU Unit, Paris-Diderot University, Paris, France.
  • Karakatsani A; CESP, Faculté de médecine (USVQ), Université Paris-Sud, INSERM, Université Paris-Saclay, Villejuif, France.
  • Trichopoulou A; Inserm UMR1018, Institut Gustave Roussy, Villejuif, France.
  • Pala V; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Masala G; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Panico S; German Institute of Human Nutrition, Potsdam-Rehbrücke, Nuthetal, Germany.
  • Tumino R; German Institute of Human Nutrition, Potsdam-Rehbrücke, Nuthetal, Germany.
  • Sacerdote C; Hellenic Health Foundation, Athens, Greece.
  • May AM; Hellenic Health Foundation, Athens, Greece.
  • van Gils CH; Pulmonary Medicine Department, School of Medicine, National and Kapodistrian University of Athens, ATTIKON University Hospital of Athens, Haidari, Greece.
  • Rylander C; Hellenic Health Foundation, Athens, Greece.
  • Borch KB; School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Chirlaque López MD; Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
  • Sánchez MJ; Cancer Risk Factors and Life-Style Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network - ISPRO, Florence, Italy.
  • Ardanaz E; Department of Clinical and Experimental Medecine, University Federico II, Naples, Italy.
  • Quirós JR; Cancer Registry and Histopathology Department, Civic M.P.Arezzo Hospital, Ragusa, Italy.
  • Amiano Exezarreta P; Unit of Cancer Epidemiology, Città della Salute e della Scienza University, Hospital and Center for Cancer Prevention (CPO), Turin, Italy.
  • Sund M; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Drake I; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Regnér S; Department of Community Medicine, Faculty of Health Sciences, University of Tromsø, The Arctic University of Norway, Tromsø, Norway.
  • Travis RC; Department of Community Medicine, Faculty of Health Sciences, University of Tromsø, The Arctic University of Norway, Tromsø, Norway.
  • Wareham N; Department of Epidemiology, Regional Health Council, IMIB-Arrixaca, Murcia University, Murcia, Spain.
  • Aune D; Spanish Consortium for Research and Public Health (CIBERESP), Madrid, Spain.
  • Riboli E; Spanish Consortium for Research and Public Health (CIBERESP), Madrid, Spain.
  • Gunter MJ; Escuela Andaluza de Salud Pública, Instituto de Investigación Biosanitaria, Universidad de Granada, Granada, Spain.
  • Duell EJ; Spanish Consortium for Research and Public Health (CIBERESP), Madrid, Spain.
  • Brennan P; Navarra Public Health Institute, Pamplona, Spain.
  • Ferrari P; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.
Eur J Epidemiol ; 35(10): 975-986, 2020 Oct.
Article em En | MEDLINE | ID: mdl-31564045
ABSTRACT
Pancreatic cancer (PC) is a highly fatal cancer with currently limited opportunities for early detection and effective treatment. Modifiable factors may offer pathways for primary prevention. In this study, the association between the Healthy Lifestyle Index (HLI) and PC risk was examined. Within the European Prospective Investigation into Cancer and Nutrition cohort, 1113 incident PC (57% women) were diagnosed from 400,577 participants followed-up for 15 years (median). HLI scores combined smoking, alcohol intake, dietary exposure, physical activity and, in turn, overall and central adiposity using BMI (HLIBMI) and waist-to-hip ratio (WHR, HLIWHR), respectively. High values of HLI indicate adherence to healthy behaviors. Cox proportional hazard models with age as primary time variable were used to estimate PC hazard ratios (HR) and 95% confidence intervals (CI). Sensitivity analyses were performed by excluding, in turn, each factor from the HLI score. Population attributable fractions (PAF) were estimated assuming participants' shift to healthier lifestyles. The HRs for a one-standard deviation increment of HLIBMI and HLIWHR were 0.84 (95% CI 0.79, 0.89; ptrend = 4.3e-09) and 0.77 (0.72, 0.82; ptrend = 1.7e-15), respectively. Exclusions of smoking from HLIWHR resulted in HRs of 0.88 (0.82, 0.94; ptrend = 4.9e-04). The overall PAF estimate was 19% (95% CI 11%, 26%), and 14% (6%, 21%) when smoking was removed from the score. Adherence to a healthy lifestyle was inversely associated with PC risk, beyond the beneficial role of smoking avoidance. Public health measures targeting compliance with healthy lifestyles may have an impact on PC incidence.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Exercício Físico / Estilo de Vida Saudável Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Female / Humans / Male Idioma: En Revista: Eur J Epidemiol Assunto da revista: EPIDEMIOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Exercício Físico / Estilo de Vida Saudável Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Female / Humans / Male Idioma: En Revista: Eur J Epidemiol Assunto da revista: EPIDEMIOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: França